BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments January 19, 2023
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology January 10, 2023
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore December 14, 2022
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology December 6, 2022
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology October 24, 2022
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base October 7, 2022
